NVCT (STOCKS)
Nuvectis Pharma, Inc. Common Stock
$18.930000
+0.930000 (+5.17%)
Prev close: $18.000000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Ronald E. Bentsur
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $616.97M
- Employees
- 13
- P/E (TTM)
- -14.09
- P/B (TTM)
- 52.91
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.30 | $-0.27 | -0.0328 | -12.28% |
|
Mar 2026 (Q1)
|
$-0.26 | $-0.32 | +0.0562 | +17.77% |
|
Dec 2025 (Q4)
|
$-0.31 | $-0.30 | -0.0065 | -2.14% |
|
Sep 2025 (Q3)
|
$-0.33 | $-0.25 | -0.0775 | -30.69% |